Supramolecular platinum complexes for cancer therapy

Area of Science:

• Supramolecular Chemistry
• Materials Science
• Medicinal Chemistry

Background:

• Supramolecular chemistry provides innovative tools for designing advanced therapeutics and drug delivery systems.
• Platinum (Pt) compounds are crucial in cancer treatment, but conventional drugs face challenges like resistance and toxicity.
• Host-guest interactions and self-assembly are key supramolecular strategies for developing new drug platforms.

Purpose of the Study:

• To review recent advancements in supramolecular platinum (Pt) complexes for cancer therapy.
• To highlight the design of novel Pt complexes utilizing host-guest interactions and self-assembly.
• To explore their potential as anticancer agents and sophisticated drug delivery systems.

Main Methods:

• Focuses on five distinct categories of supramolecular Pt complexes.
• Includes host-guest complexes of FDA-approved Pt(II) drugs.
• Covers supramolecular complexes of nonclassical Pt(II) metallodrugs, Pt(IV) prodrugs, and self-assembled Pt-based metallosupramolecules.

Main Results:

• Supramolecular Pt complexes integrate the therapeutic benefits of Pt with advanced supramolecular structures.
• These complexes range from small host-guest systems to large metallosupramolecules and nanoparticles.
• Novel designs inspired by supramolecular approaches aim to surmount challenges associated with conventional Pt-based chemotherapy.

Conclusions:

• Supramolecular Pt complexes represent a promising frontier in oncology, offering enhanced therapeutic efficacy and targeted delivery.
• The integration of Pt compounds with supramolecular architectures provides a versatile platform for next-generation anticancer drugs.
• Further research into these complexes could lead to improved patient outcomes and overcome drug resistance mechanisms.